Financials
- Market Capitalization 22.86 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.41
売上高対価格比率
3.86
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 524 | UTHR United Therapeutics Corporation - Common Stock | 549.16 USD | +3.07% | +1.60% | +8.38% | +25.51% | 23.55 B USD | ||
| 528 | BNTX BioNTech SE - American Depositary Shares | 96.96 USD | +5.32% | +0.23% | -4.95% | -4.94% | 23.27 B USD | ||
| 543 | INSM Insmed Incorporated - Common Stock | 100.60 USD | +0.12% | -4.64% | -22.32% | -37.92% | 21.97 B USD | ||
| 685 | EXEL Exelixis, Inc. - Common Stock | 59.86 USD | +1.42% | +2.57% | +6.06% | +53.33% | 14.83 B USD |